ORIX Capital Corporation is an institutional investor (Conventional VCs) founded in 1983 and headquartered in Tokyo, Japan. ORIX Capital is a venture capital investment company. Geographies of interest include Japan. Invests in multiple sectors like Biopharma, Gaming, Manufacturing and Drug Discovery. Top investments include REGiMMUNE, UMN Pharma, Shannon, Edia. Notable portfolio companies: REGiMMUNE, UMN Pharma, Shannon, Edia.

Stage

middle-market control private equity, buyouts (founder-owned, PE-backed, corporate divestitures), middle-market control private equity, buyouts (founder-owned, PE-backed, corporate divestitures)

Check size

$75M-$250M equity

HQ

Tokyo, Japan

Founded

1983

Website

https://orixcapital.co.jp

What they look for

North America; EBITDA $10M-$75M; profitable scalable businesses in fragmented asset-light industries; strong organic/inorganic growth potential, differentiated products/services, excellent leadership, positive culture, strong customer relationships

Preparing to pitch ORIX Capital Corporation?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.